In vivo endotoxin tolerance: Impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but not SIRS

Journal of Surgical Research

Volumn 69, Issue 1, 1997, Pages 101-106

  Wilson, Christopher S ^a,b   Seatter, Susan C ^a,b   Rodriguez, Jorge L ^a   Bellingham, Janet ^b   Clair, Laurel ^b   West, Michael A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

BIOASSAY; CONFERENCE PAPER; DOSE RESPONSE; HUMAN; HYPOTHESIS; INFORMED CONSENT; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS;

EID: 0031127614     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5040     Document Type: Conference Paper

References (38)

1. 1. Beal, A. L., and Cerra, F. B. Multiple organ failure syndrome in the 1990's. J. Am. Med. Assoc. 271: 226, 1994.
2. 2. Bone, R. C. Sepsis and its complications: The clinical problem. Crit. Care Med. 22: S8, 1994.
3. 3. Glauser, M. P., Heumann, D., Baumgartner, J. D., and Cohen, J. Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clin. Infect. Dis. 18: S205, 1994.
4. 4. Heumann, D., Barras, C., Severin, A., Glauser, M.-P., and Tomasz, A. Gram positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62: 2715, 1994.
5. 5. Michie, H. R., Manogue, K. R., and Spriggs, D. R. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318: 1481, 1988.
6. 6. Munoz, C., Carlet, J., Fitting, C., Misset, B., Bleriot, J.-P., and Cavaillon, J.-M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747, 1991.
7. 7. LeMay, D. R., LeMay, L. G., Kluger, M. J., and D'alecy, L. G. Plasma profiles of IL-6 and TNF with fever inducing doses of lipopolysaccharide in dogs. Am. J. Physiol. 259: R126, 1991.
8. 8. Largen, M. T., and Tannenbaum, C. S. LPS regulation of specific protein synthesis in murine peritoneal macrophages. J. Immunol. 136: 988, 1986.
9. 9. Fong, Y., Moldawer, L. L., Marano, M., et al. Endotoxemia elicits increased beta2-IFN/ IL-6 in man. J. Immunol. 142: 2321, 1989.
10. 10. West, M. A., Seatter, S. C., Bellingham, J., and Clair, L. Mechanisms of reprogrammed macrophage endotoxin (LPS) signal transduction after LPS pretreatment. Surgery 118: 220, 1995.
11. 11. Ziegler-Heitbrock, H. W. L., Wedel, A., Schraut, W., Strobel, M., Wendelgass, P., Sternsdorf, T., Bauerle, P. A., Haas, J. G., and Reithmuller, G. Tolerance to lipopolysaccharide involves mobilization of nuclear factor KB with predominance of p50 homodimers. J. Biol. Chem. 269: 17001, 1994.
12. 12. Calandra, T., Baumgartner, J.-D., Grau, G. E., Wu, M.-M. et al. Prognostic values of tumor necrosis factor/ cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J. Infect. Dis. 161: 982, 1990.
13. 13. Damas, P., Reuter, A., Gysen, P., Demonty, J., Lamy, M., and Franchimont, P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17: 975, 1989.
14. 14. Offner, F., Phillipe, J., Vagelaers, D., Colerdyn, G., Baele, G., Baudrihave, M., et al. Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J. Lab. Clin. Med. 116: 100, 1990.
15. 15. Nathan, C. F. Secretory products of macrophages. J. Clin. Invest. 79: 319, 1987.
16. 16. Beutler, B., Greenwald, D., and Hulmes, J. D. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552, 1985.
17. 17. Dinarello, C. A. Interleukin-1. Rev. Infect. Dis. 6: 51, 1984.
18. 18. West, M. A., Seatter, S. C., Clair, L., Bellingham, J., and Bennett, T. LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation. J. Leukocyte Biol. 61: 88, 1997.
19. 19. Seatter, S. C., Bergren, T., Li, M. H., Bubrick, M. P., and West, M. A. Macrophage endotoxin tolerance: Tumor necrosis factor and interleukin-1 regulation by lipopolysaccharide pretreatment. Arch. Surg. 129: 1263, 1994.
20. 20. Seatter, S. C., Li, M. H., Bubrick, M. P., and West, M. A. Endotoxin pretreatment of human monocytes alters subsequent endotoxin-triggered release of inflammatory mediators. Shock 3: 252, 1995.
21. 21. Li, M. H., Seatter, S. C., Manthei, R., Bubrick, M. P., and West, M. A. Macrophage endotoxin tolerance: Effect of TNF or endotoxin pretreatment. J. Surg. Res. 57: 85, 1994.
22. 22. Zhang, X., and Morrison, D. C. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukocyte Biol. 54: 444, 1993.
23. 23. Committee, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 864, 1992.
24. 24. Marshall, J. C., Cook, D. J., Christou, N. V., Bernard, G. R., Sprung, C. L., and Sibbald, W. J. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 23: 1638, 1995.
25. 25. Aggarwal, B. B. Human lymphotoxin. Methods Enzymol. 116: 441, 1985.
26. 26. Moss, M., Goodman, P. L., Heinig, M., Barkin, S., Ackerson, L., and Parsons, P. E. Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome. Crit. Care Med. 23: 1629, 1995.
27. 27. Cerra, F. B. Infection, the inflammatory response, and multiple organ dysfunction. In R. Howard and R. L. Simmons (Eds.), Surgical Infectious Diseases. Norwalk, CT: Appleton & Lange, 1995. P. 387.
28. 28. Zhang, X., and Morrison, D. C. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177: 511, 1993.
29. 29. Yoshimoto, T., Nakanishi, K., Hirose, S., Hiroishi, K., Okamura, H., Takemoto, Y., Kanamaru, A., Hada, T., Tamura, T., Kakishita, E., and Higashino, K. High serum IL-6 levels reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J. Immunol. 148: 3596, 1992.
30. 30. Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Brunn, J. N., Halvorsen, S., and Sorenson, E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic menningococcal disease. J. Infect. Dis. 159: 195, 1989.
31. 2 release. Surg. Forum 49: 74, 1993.
32. 32. Marks, J. D., Marks, C. B., Luce, J. M., Montgomery, B., Turner, J., Metz, C. A., and Murray, J. F. Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am. Rev. Resp. Dis. 141: 94, 1990.
33. 33. Haas, J. G., Thiel, C., Blomer, K., Weiss, Elisabeth H., Riethmuller, G., and Ziegler-Heitbrock, H. W. L. Down regulation of tumor necrosis factor expression in the human mono-Mac-6 cell line by lipopoysacchride. J. Leukocyte Biol. 43: 11, 1989.
34. 34. Burchett, S. K., Weaver, W. M., Westall, J. A., et al. Regulation of tumor necrosis factor/ cachectin and IL-1 secretion in human mononuclear phagocytes. J. Immunol. 140: 3473, 1988.
35. 35. Arend, W. P., Gordon, D. F., Wood, W. M., Janson, R. W., Joslin, F. G., and Jameel, S. IL-β production in cultured human mono-cytes is regulated at multiple levels. J. Immunol. 143: 118, 1989.
36. 36. Ikejima, T., Okusawa, S., Ghezzi, P., et al. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J. Infect. Dis. 162: 215, 1990.
37. 37. Smith, D. M., Lackides, G. A., and Epstein, L. B. Coordinated induction of autocrine tumor necrosis factor and interleukin-1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity. Cancer Res. 50: 3146, 1990.
38. 38. Girardin, E., Grau, G. E., Bayer, J. M., et al. Circulating tumor necrosis factor and interleukin-1 in the serum of children with infectious purpura. N. Engl. J. Med. 319: 397, 1988.